Details of the Drug

General Information of Drug (ID: DME7B2O)

• Drug Name: SER-401

Indication

Disease Entry	ICD 11	Status	REF
Metastatic melanoma	2E2Z	Phase 1	[1]

• Drug Type: Live biotherapeutic product
• Cross-matching ID: TTD ID: DT2B6G

References

• [1] ClinicalTrials.gov (NCT03817125) Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention (MCGRAW). U.S. National Institutes of Health.